Report Detail
Global Infectious Vaccines Market Insights, Forecast to 2025
- RnM3480217 |
- 17 July, 2020 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Infectious Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Infectious Vaccines market is segmented into
Preventive vaccine
Therapeutic vaccine
Segment by Application, the Infectious Vaccines market is segmented into
Adults
Pediatrics
Regional and Country-level Analysis
The Infectious Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Infectious Vaccines Market Share Analysis
Infectious Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Infectious Vaccines business, the date to enter into the Infectious Vaccines market, Infectious Vaccines product introduction, recent developments, etc.
The major vendors covered:
CSL Limited (Australia)
Bavarian Nordic (Denmark)
GlaxoSmithKline plc. (U.K.)
Emergent Bio Solutions Inc. (U.S.)
MedImmune LLC (U.S.)
Johnson and Johnson (U.S.)
Novartis AG (Switzerland)
Merck and Company (U.S.)
Sanofi Pasteur (France)
Pfizer Inc. (U.S.)
1 Study Coverage
- 1.1 Infectious Vaccines Product Introduction
- 1.2 Market Segments
- 1.3 Key Infectious Vaccines Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Infectious Vaccines Market Size Growth Rate by Type
- 1.4.2 Preventive vaccine
- 1.4.3 Therapeutic vaccine
- 1.5 Market by Application
- 1.5.1 Global Infectious Vaccines Market Size Growth Rate by Application
- 1.5.2 Adults
- 1.5.3 Pediatrics
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Infectious Vaccines Market Size, Estimates and Forecasts
- 2.1.1 Global Infectious Vaccines Revenue 2015-2026
- 2.1.2 Global Infectious Vaccines Sales 2015-2026
- 2.2 Global Infectious Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Infectious Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Infectious Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Infectious Vaccines Competitor Landscape by Players
- 3.1 Infectious Vaccines Sales by Manufacturers
- 3.1.1 Infectious Vaccines Sales by Manufacturers (2015-2020)
- 3.1.2 Infectious Vaccines Sales Market Share by Manufacturers (2015-2020)
- 3.2 Infectious Vaccines Revenue by Manufacturers
- 3.2.1 Infectious Vaccines Revenue by Manufacturers (2015-2020)
- 3.2.2 Infectious Vaccines Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Infectious Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Infectious Vaccines Revenue in 2019
- 3.2.5 Global Infectious Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Infectious Vaccines Price by Manufacturers
- 3.4 Infectious Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Infectious Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Infectious Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Infectious Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Infectious Vaccines Market Size by Type (2015-2020)
- 4.1.1 Global Infectious Vaccines Sales by Type (2015-2020)
- 4.1.2 Global Infectious Vaccines Revenue by Type (2015-2020)
- 4.1.3 Infectious Vaccines Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Infectious Vaccines Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Infectious Vaccines Sales Forecast by Type (2021-2026)
- 4.2.2 Global Infectious Vaccines Revenue Forecast by Type (2021-2026)
- 4.2.3 Infectious Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Infectious Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Infectious Vaccines Market Size by Application (2015-2020)
- 5.1.1 Global Infectious Vaccines Sales by Application (2015-2020)
- 5.1.2 Global Infectious Vaccines Revenue by Application (2015-2020)
- 5.1.3 Infectious Vaccines Price by Application (2015-2020)
- 5.2 Infectious Vaccines Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Infectious Vaccines Sales Forecast by Application (2021-2026)
- 5.2.2 Global Infectious Vaccines Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Infectious Vaccines Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Infectious Vaccines by Country
- 6.1.1 North America Infectious Vaccines Sales by Country
- 6.1.2 North America Infectious Vaccines Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Infectious Vaccines Market Facts & Figures by Type
- 6.3 North America Infectious Vaccines Market Facts & Figures by Application
7 Europe
- 7.1 Europe Infectious Vaccines by Country
- 7.1.1 Europe Infectious Vaccines Sales by Country
- 7.1.2 Europe Infectious Vaccines Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Infectious Vaccines Market Facts & Figures by Type
- 7.3 Europe Infectious Vaccines Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Infectious Vaccines by Region
- 8.1.1 Asia Pacific Infectious Vaccines Sales by Region
- 8.1.2 Asia Pacific Infectious Vaccines Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Infectious Vaccines Market Facts & Figures by Type
- 8.3 Asia Pacific Infectious Vaccines Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Infectious Vaccines by Country
- 9.1.1 Latin America Infectious Vaccines Sales by Country
- 9.1.2 Latin America Infectious Vaccines Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Infectious Vaccines Market Facts & Figures by Type
- 9.3 Central & South America Infectious Vaccines Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Infectious Vaccines by Country
- 10.1.1 Middle East and Africa Infectious Vaccines Sales by Country
- 10.1.2 Middle East and Africa Infectious Vaccines Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Infectious Vaccines Market Facts & Figures by Type
- 10.3 Middle East and Africa Infectious Vaccines Market Facts & Figures by Application
11 Company Profiles
- 11.1 CSL Limited (Australia)
- 11.1.1 CSL Limited (Australia) Corporation Information
- 11.1.2 CSL Limited (Australia) Description and Business Overview
- 11.1.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
- 11.1.5 CSL Limited (Australia) Related Developments
- 11.2 Bavarian Nordic (Denmark)
- 11.2.1 Bavarian Nordic (Denmark) Corporation Information
- 11.2.2 Bavarian Nordic (Denmark) Description and Business Overview
- 11.2.3 Bavarian Nordic (Denmark) Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Bavarian Nordic (Denmark) Infectious Vaccines Products Offered
- 11.2.5 Bavarian Nordic (Denmark) Related Developments
- 11.3 GlaxoSmithKline plc. (U.K.)
- 11.3.1 GlaxoSmithKline plc. (U.K.) Corporation Information
- 11.3.2 GlaxoSmithKline plc. (U.K.) Description and Business Overview
- 11.3.3 GlaxoSmithKline plc. (U.K.) Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 GlaxoSmithKline plc. (U.K.) Infectious Vaccines Products Offered
- 11.3.5 GlaxoSmithKline plc. (U.K.) Related Developments
- 11.4 Emergent Bio Solutions Inc. (U.S.)
- 11.4.1 Emergent Bio Solutions Inc. (U.S.) Corporation Information
- 11.4.2 Emergent Bio Solutions Inc. (U.S.) Description and Business Overview
- 11.4.3 Emergent Bio Solutions Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Emergent Bio Solutions Inc. (U.S.) Infectious Vaccines Products Offered
- 11.4.5 Emergent Bio Solutions Inc. (U.S.) Related Developments
- 11.5 MedImmune LLC (U.S.)
- 11.5.1 MedImmune LLC (U.S.) Corporation Information
- 11.5.2 MedImmune LLC (U.S.) Description and Business Overview
- 11.5.3 MedImmune LLC (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 MedImmune LLC (U.S.) Infectious Vaccines Products Offered
- 11.5.5 MedImmune LLC (U.S.) Related Developments
- 11.6 Johnson and Johnson (U.S.)
- 11.6.1 Johnson and Johnson (U.S.) Corporation Information
- 11.6.2 Johnson and Johnson (U.S.) Description and Business Overview
- 11.6.3 Johnson and Johnson (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Johnson and Johnson (U.S.) Infectious Vaccines Products Offered
- 11.6.5 Johnson and Johnson (U.S.) Related Developments
- 11.7 Novartis AG (Switzerland)
- 11.7.1 Novartis AG (Switzerland) Corporation Information
- 11.7.2 Novartis AG (Switzerland) Description and Business Overview
- 11.7.3 Novartis AG (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Novartis AG (Switzerland) Infectious Vaccines Products Offered
- 11.7.5 Novartis AG (Switzerland) Related Developments
- 11.8 Merck and Company (U.S.)
- 11.8.1 Merck and Company (U.S.) Corporation Information
- 11.8.2 Merck and Company (U.S.) Description and Business Overview
- 11.8.3 Merck and Company (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Merck and Company (U.S.) Infectious Vaccines Products Offered
- 11.8.5 Merck and Company (U.S.) Related Developments
- 11.9 Sanofi Pasteur (France)
- 11.9.1 Sanofi Pasteur (France) Corporation Information
- 11.9.2 Sanofi Pasteur (France) Description and Business Overview
- 11.9.3 Sanofi Pasteur (France) Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Sanofi Pasteur (France) Infectious Vaccines Products Offered
- 11.9.5 Sanofi Pasteur (France) Related Developments
- 11.10 Pfizer Inc. (U.S.)
- 11.10.1 Pfizer Inc. (U.S.) Corporation Information
- 11.10.2 Pfizer Inc. (U.S.) Description and Business Overview
- 11.10.3 Pfizer Inc. (U.S.) Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Pfizer Inc. (U.S.) Infectious Vaccines Products Offered
- 11.10.5 Pfizer Inc. (U.S.) Related Developments
- 11.1 CSL Limited (Australia)
- 11.1.1 CSL Limited (Australia) Corporation Information
- 11.1.2 CSL Limited (Australia) Description and Business Overview
- 11.1.3 CSL Limited (Australia) Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 CSL Limited (Australia) Infectious Vaccines Products Offered
- 11.1.5 CSL Limited (Australia) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Infectious Vaccines Market Estimates and Projections by Region
- 12.1.1 Global Infectious Vaccines Sales Forecast by Regions 2021-2026
- 12.1.2 Global Infectious Vaccines Revenue Forecast by Regions 2021-2026
- 12.2 North America Infectious Vaccines Market Size Forecast (2021-2026)
- 12.2.1 North America: Infectious Vaccines Sales Forecast (2021-2026)
- 12.2.2 North America: Infectious Vaccines Revenue Forecast (2021-2026)
- 12.2.3 North America: Infectious Vaccines Market Size Forecast by Country (2021-2026)
- 12.3 Europe Infectious Vaccines Market Size Forecast (2021-2026)
- 12.3.1 Europe: Infectious Vaccines Sales Forecast (2021-2026)
- 12.3.2 Europe: Infectious Vaccines Revenue Forecast (2021-2026)
- 12.3.3 Europe: Infectious Vaccines Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Infectious Vaccines Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Infectious Vaccines Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Infectious Vaccines Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Infectious Vaccines Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Infectious Vaccines Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Infectious Vaccines Sales Forecast (2021-2026)
- 12.5.2 Latin America: Infectious Vaccines Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Infectious Vaccines Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Infectious Vaccines Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Infectious Vaccines Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Infectious Vaccines Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Infectious Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Infectious Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Infectious Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Infectious Vaccines . Industry analysis & Market Report on Infectious Vaccines is a syndicated market report, published as Global Infectious Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Infectious Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
